Mounjaro is manufactured by Eli Lilly and Company, a major US-based pharmaceutical firm. The manufacturing includes facilities in the United States, notably a large facility in Kenosha County, Wisconsin, that Lilly spent $3 billion to expand for producing injectable medicines like Mounjaro. Eli Lilly also has production facilities supporting the global rollout of Mounjaro in other locations including Ireland, Italy, and Spain. Additionally, Eli Lilly is investing in new manufacturing facilities in the US, including a $6.5 billion site in Houston, Texas, aimed at expanding production capacity for related medicines. This reflects a broad manufacturing and expansion effort by Eli Lilly for Mounjaro and related drugs worldwide.
